Stage IV Pancreatic Cancer Terminated Phase 2 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0028776 (Stage IV Pancreatic Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01851174Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic CancerTreatment